The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Programmed Death-1 (PD-1) is a Marker of Germinal Center-associated T Cells and Angioimmunoblastic T-Cell Lymphoma
Open accessAbstract
Programmed death-1 (PD-1), a member of the CD28 costimulatory receptor family, is expressed by germinal center-associated T cells in reactive lymphoid tissue. In a study of a wide range of lymphoproliferative disorders, neoplastic T cells in 23 cases of angioimmunoblastic lymphoma were immunoreactive for PD-1, but other subtypes of T cell and B cell non-Hodgkin lymphoma, as well as classic Hodgkin lymphoma, did not express PD-1. The pattern of PD-1 immunostaining of neoplastic cells in angioimmunoblastic lymphoma was similar to that reported for CD10, a recently described marker of neoplastic T cells in angioimmunoblastic lymphoma. Tumor-associated follicular dendritic cells in cases of angioimmunoblastic lymphoma were found to express PD-L1, the PD-1 ligand. In addition, PD-1-positive reactive T cells formed rosettes around neoplastic L&H cells in 14 cases of nodular lymphocyte predominant Hodgkin lymphoma studied. These findings, along with data from previous studies, suggest that angioimmunoblastic lymphoma is a neoplasm of germinal center-associated T cells and that there is an association of germinal center-associated T cells and neoplastic cells in nodular lymphocyte predominant Hodgkin lymphoma. PD-1 is a useful new marker for angioimmunoblastic lymphoma and lends further support to a model of T-cell lymphomagenesis in which specific subtypes of T cells may undergo neoplastic transformation and result in specific, distinct histologic, immunophenotypic, and clinical subtypes of T-cell neoplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
Self-citationPathology and genetics: Tumours of haematopoietic and lymphoid tissues
Vyas, P. (2001) · The Lancet Oncology · Cited by 988
Brown, J. A., Dorfman, D. M., Ma, F.-R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., & Freeman, G. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1257 · Cited by 968
Self-citationChtanova, T., Tangye, S. G., Newton, R., Frank, N., Hodge, M. R., Rolph, M. S., & Mackay, C. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.68 · Cited by 722
Subspecialization of Cxcr5+ T Cells
Kim, C. H., Rott, L. S., Clark-Lewis, I., Campbell, D. J., Wu, L., & Butcher, E. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1373 · Cited by 625
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4
Probst, H. C., McCoy, K., Okazaki, T., Honjo, T., & van den Broek, M. (2005) · Nature Immunology · doi:10.1038/ni1165 · Cited by 554
Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10
Attygalle, A. D., Al-Jehani, R. M., Diss, T. C., Munson, P., Liu, H., Du, M., Isaacson, P. G., & Doǧan, A. (2002) · Blood · doi:10.1182/blood.v99.2.627 · Cited by 353
Marafioti, T., Hummel, M., Anagnostopoulos, I., Foss, H.-D., Falini, B., Delsol, G., Isaacson, P. G., Pileri, S., & Stein, H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370703 · Cited by 327
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
Riley, J. L., & June, C. H. (2005) · Blood · doi:10.1182/blood-2004-04-1596 · Cited by 315
Braeuninger, A., Küppers, R., Strickler, J. G., Wacker, H.-H., Rajewsky, K., & Hansmann, M.-L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9337 · Cited by 270
Jones, D., O’Hara, C., Kraus, M. D., Pérez‐Atayde, A. R., Shahsafaei, A., Wu, L., & Dorfman, D. M. (2000) · Blood · doi:10.1182/blood.v96.2.685 · Cited by 151
Self-citationArber, D. A., & Weiss, L. M. (1997) · Applied Immunohistochemistry · doi:10.1097/00022744-199709000-00001 · Cited by 91
Microanatomical localization of PD-1 in human tonsils
Iwai, Y., Okazaki, T., Nishimura, H., Koyanagi, A., Yagita∥, H., & Honjo, T. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00088-3 · Cited by 74
Dorfman, D. M., Hwang, E. S., Shahsafaei, A., & Glimcher, L. H. (2004) · American Journal of Clinical Pathology · doi:10.1309/aqq2dvm75dvy0pwp · Cited by 70
Self-citationDorfman, D. M., Greisman, H. A., & Shahsafaei, A. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64287-3 · Cited by 48
Self-citationJones, D., Fletcher, C. D. �., Pulford, K. A. F., Shahsafaei, A., & Dorfman, D. M. (1999) · Blood · doi:10.1182/blood.v93.10.3487.410k39_3487_3493 · Cited by 43
Self-citation
Cited by
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Self-citationAlaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., Araujo, I. B. D. O., Berti, E., Bhagat, G., Borges, A. M., Boyer, D., Calaminici, M., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01620-2 · Cited by 4,004
Follicular Helper CD4 T Cells (T FH )
Crotty, S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101400 · Cited by 2,738
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Self-citationPD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
Self-citation
Metadata
- Authors
- Dorfman, D. M., Brown, J. A., Shahsafaei, A., & Freeman, G. J.
- Venue
- American Journal of Surgical Pathology
- Published
- 2006-07
- Volume
- 30
- Issue
- 7
- Pages
- 802-810
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W1985563120
- Cited by
- 358
- References
- 16
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.